Andreas Polychronis

2.4k citations
34 papers · 1.1k · 1 hit paper · h-index 13

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Lung Cancer Research Studies

Papers in

Andreas Polychronis

28 papers receiving 1.1k citations

Andreas Polychronis's Hit Papers

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study 2018 · 342 citations
3420+2+5Years since publication100200300

Peers

Andreas Polychronis
Comparison fields: 5 of 87
  • Oncology 520
  • Family Practice 16
  • Pulmonary and Respiratory Medicine 223
  • General Health Professions 160
  • Cancer Research 95
Replace Urban Nylén with:
Urban Nylén Sweden
Rebecca I. Hartman United States
Rhiannon Walters Australia
Kimberly S. Peairs United States
Aaron Philip Mitchell United States
Grainne M. O’Kane Canada
Jill Kolesar United States
Á. Izquierdo Spain
Jennifer Obel United States
Sara H. Javid United States
Andreas Polychronis relative to Urban Nylén Sweden Urban Nylén's profile →
Citations per field
00.5×
Urban Nylén · 1×
Citations per year

Countries citing papers authored by Andreas Polychronis

Since Specialization
Citations

This map shows the geographic impact of Andreas Polychronis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Polychronis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Polychronis more than expected).

Fields of papers citing papers by Andreas Polychronis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Polychronis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Polychronis. The network helps show where Andreas Polychronis may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Polychronis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Polychronis Line = papers co-authored together Andreas Polychronis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
Hit paper breakdown →
2018342
2 2005160
3 2009115
4 200775
5 199768
6 201857
7 200746
8 200344
9 202141
10 200433
11 199624
12 202123
13 201914
14 202011
15 201510
16
A rare occurrence of biphasic pulmonary blastoma in an elderly male.
20139
17 19967
18 19957
19 20056
20 20245

About Andreas Polychronis

Andreas Polychronis is a scholar working on General Health Professions, Oncology, Surgery, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Primary Care and Health Outcomes (6 papers), Health Sciences Research and Education (4 papers), Clinical practice guidelines implementation (3 papers), Occupational and environmental lung diseases (3 papers), Healthcare Quality and Management (3 papers), Cancer Mechanisms and Therapy (2 papers), Facial Rejuvenation and Surgery Techniques (2 papers) and Healthcare cost, quality, practices (2 papers). The work is most often cited by research in Oncology (520 citations), Family Practice (16 citations), Pulmonary and Respiratory Medicine (223 citations), General Health Professions (160 citations) and Cancer Research (95 citations). Andreas Polychronis has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Joseph E Grey, A. Miles, R. Charles Coombes, P. Bentley, Luana Calabrò, Fabrice Barlési, Osvaldo Arén Frontera, Filippo de Marinis, Maciej Krzakowski and Marcis Bajars. Their work appears in journals such as Journal of Evaluation in Clinical Practice, Lung Cancer, The Lancet Oncology, Journal of Clinical Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact